105 related articles for article (PubMed ID: 18378243)
1. LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin.
Martin-Ventura JL; Blanco-Colio LM; Aparicio C; Ortega L; Esbrit P; Egido J
Atherosclerosis; 2008 Jun; 198(2):264-71. PubMed ID: 18378243
[TBL] [Abstract][Full Text] [Related]
2. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis.
Martín-Ventura JL; Ortego M; Esbrit P; Hernández-Presa MA; Ortega L; Egido J
Stroke; 2003 Jul; 34(7):1783-9. PubMed ID: 12805493
[TBL] [Abstract][Full Text] [Related]
3. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
5. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
7. Expression and biological activity of parathyroid hormone-related peptide in pregnant rat uterine artery: any role for 8-iso-prostaglandin F2alpha?
Meziani F; Tesse A; Welsch S; Kremer H; Barthelmebs M; Andriantsitohaina R; Schneider F; Gairard A
Endocrinology; 2008 Feb; 149(2):626-33. PubMed ID: 18048500
[TBL] [Abstract][Full Text] [Related]
8. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
9. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
Llorente-Cortés V; Martínez-González J; Badimon L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
Alfon J; Guasch JF; Berrozpe M; Badimon L
Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension.
Massfelder T; Taesch N; Endlich N; Eichinger A; Escande B; Endlich K; Barthelmebs M; Helwig JJ
FASEB J; 2001 Mar; 15(3):707-18. PubMed ID: 11259389
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation.
Crespo J; Martínez-González J; Rius J; Badimon L
Cardiovasc Res; 2005 Aug; 67(2):333-41. PubMed ID: 16005304
[TBL] [Abstract][Full Text] [Related]
15. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin.
Muñoz-García B; Martín-Ventura JL; Martínez E; Sánchez S; Hernández G; Ortega L; Ortiz A; Egido J; Blanco-Colio LM
Stroke; 2006 Aug; 37(8):2044-53. PubMed ID: 16809572
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein.
Nyby MD; Hino T; Berger ME; Ormsby BL; Golub MS; Brickman AS
Endocrinology; 1995 Jun; 136(6):2497-504. PubMed ID: 7750471
[TBL] [Abstract][Full Text] [Related]
17. Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells.
Song GJ; Fiaschi-Taesch N; Bisello A
Mol Endocrinol; 2009 Oct; 23(10):1681-90. PubMed ID: 19574446
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
Song JX; Ren JY; Chen H
J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin.
Kang S; Woo HH; Kim K; Lim KM; Noh JY; Lee MY; Bae YM; Bae ON; Chung JH
Toxicol Sci; 2014 Apr; 138(2):446-556. PubMed ID: 24449418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
